from Reuters: Business News https://ift.tt/2JITbPQ
Tuesday, November 6, 2018
Drugmaker Lilly's third-quarter profit more than doubles
U.S. drugmaker Eli Lilly and Co's third-quarter profit more than doubled, led by higher demand for its newer treatments such as diabetes drug Trulicity and psoriasis medicine Taltz.
from Reuters: Business News https://ift.tt/2JITbPQ
from Reuters: Business News https://ift.tt/2JITbPQ
Related Posts:
Malaysia's 1MDB criminal case against Goldman Sachs delayed to September- Scandal-hit Nomura wins shareholder approval for re-appointment of CEO
- U.S. regulators ask Deutsche Bank to explain 'bad bank' proposal: FT
- Oil prices extend gains, U.S.-Iran tensions in focus
- Asian stocks tick up, oil rises amid U.S.-Iran tensions
0 comments:
Post a Comment